Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results
- Resource Type
- Article
- Authors
- Yacoub, Abdulraheem; Borate, Uma; Rampal, Raajit K.; Ali, Haris; Wang, Eunice S.; Gerds, Aaron T.; Hobbs, Gabriela; Kremyanskaya, Marina; Winton, Elliott; O’Connell, Casey; Goel, Swati; Oh, Stephen T.; Schiller, Gary; McCloskey, James; Palmer, Jeanne; Holmes, Houston; Hager, Steven; Assad, Albert; Erickson-Viitanen, Susan; Zhou, Feng; Daver, Naval
- Source
- In Blood Advances 26 March 2024 8(6):1515-1528
- Subject
- Myeloid Neoplasia
Clinical Trials and Observations
- Language
- ISSN
- 2473-9529